SARS-CoV-2,
Showing 76 - 100 of >10,000
Awake Prone Positioning in COVID-19 ICU Patients
Not yet recruiting
- SARS-CoV 2 Pneumonia
- quality of life questionnaire
-
Tours, Franceuniversity hospital Tours
Oct 10, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Influenza, COVID-19, RSV Infection Trial (Collection of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs)
Not yet recruiting
- Influenza
- +2 more
- Collection of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs
- (no location specified)
Mar 1, 2023
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions
Completed
- COVID-19
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
COVID19 Trial in San José (Breath sample)
Withdrawn
- COVID19
- Breath sample
-
San José, Costa RicaInstituto Costarricense de Investigaciones Clínicas
Nov 22, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
COVID-19 Trial in Beijing, Shanghai (HH-120 Nasal Spray, Placebo)
Not yet recruiting
- COVID-19
- HH-120 Nasal Spray
- Placebo
-
Beijing, China
- +1 more
Mar 27, 2023
COVID-19 Trial in Madrid (Aerobic plus strength group, Aerobic group)
Not yet recruiting
- COVID-19
- Aerobic plus strength group
- Aerobic group
-
Madrid, SpainDavid Fernández
Dec 27, 2022
Against SARS-CoV-2 (COVID-19)in Dazhu County in 2023
Recruiting
- COVID-19
-
Dazhou, Sichuan, ChinaDazhu County Center for Disease Control and Prevention
Mar 7, 2023
Covid19 Trial in Lenexa, Raleigh (Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal
Recruiting
- Covid19
- Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops
- +4 more
-
Lenexa, Kansas
- +1 more
Aug 1, 2022
COVID-19 Trial (Blood sample collection, Saliva sample collection, Nasopharyngeal and nasal sample collection)
Not yet recruiting
- COVID-19
- Blood sample collection
- +3 more
- (no location specified)
May 12, 2023
COVID-19 Trial in Nanjing, Hangzhou (20 µg dose of SYS6006, 30 µg dose of SYS6006, Placebo)
Enrolling by invitation
- SARS-CoV-2
- 20 μg dose of SYS6006 ;30 μg dose of SYS6006
- Placebo
-
Nanjing, Jiangsu, China
- +1 more
Dec 20, 2022
T7 and T12 Slices on Mortality in Resuscitation ARDS Caused by
Not yet recruiting
- Acute Respiratory Distress Syndrom (SARS-Cov 2)
- Data collection
- analysis of thoracic scans
- (no location specified)
Oct 21, 2022
SARS-CoV-2 Immune Surveillance AmongPopulation Based Sample of
Completed
- Coronavirus Infection
- SARS-CoV-2 Antibody Analysis
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Sep 30, 2022
COVID-19, SARS-CoV2 Infection Trial (Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies)
Not yet recruiting
- COVID-19
- SARS-CoV2 Infection
- Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies
- (no location specified)
Jul 14, 2022
Ventilatory and Perfusion Abnormalities in Individuals With
Recruiting
- Post-Acute COVID-19
- +3 more
- Computed Tomography of the Chest
-
Boston, MassachusettsTufts Medical Center
May 18, 2023
COVID-19, SARS-CoV-2 Infection Trial in Beijing (HH-120 Nasal Spray)
Completed
- COVID-19
- SARS-CoV-2 Infection
- HH-120 Nasal Spray
-
Beijing, Beijing, ChinaBeijing Ditan Hospital,Capital Medical University
Feb 26, 2023
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
Recruiting
- SARS-CoV-2
- SPIKEVAX
-
New York, New YorkAetion, Inc
Nov 8, 2023
Main Postoperative Complications After SARS-CoV-2 Infection
Not yet recruiting
- Intestines Cancer
- +5 more
- no intervention
- (no location specified)
Mar 12, 2023
ARDS, SARS-CoV 2 Pneumonia Trial (blood sample and bronchoalveolar lavage)
Not yet recruiting
- ARDS
- SARS-CoV 2 Pneumonia
- blood sample and bronchoalveolar lavage
- (no location specified)
Jul 18, 2022
Long COVID, Insulin Resistance, Insulin Sensitivity Trial in Palo Alto (Adipose Tissue Biopsy, Steady State Plasma Glucose
Not yet recruiting
- Long COVID
- +2 more
- Adipose Tissue Biopsy
- Steady State Plasma Glucose (SSPG) Test
-
Palo Alto, California
- +1 more
Apr 27, 2023